Avalo Therapeutics | 424B5: Prospectus
Aug 7, 2023 17:26 ET
Avalo Therapeutics | 424B5: Prospectus
May 4, 2023 17:04 ET
Avalo Therapeutics | EFFECT: Others
May 3, 2023 00:15 ET
Avalo Therapeutics | EFFECT: Others
Apr 28, 2023 00:15 ET
Avalo Therapeutics | 424B5: Prospectus
Feb 3, 2023 16:02 ET
Avalo Therapeutics | 424B5: Prospectus
Feb 2, 2023 16:03 ET
Avalo Therapeutics | 424B5: Prospectus
Sep 15, 2021 16:41 ET
Avalo Therapeutics | 424B5: Prospectus
Sep 14, 2021 16:05 ET
Avalo Therapeutics | EFFECT: Others
Mar 22, 2021 00:15 ET
Avalo Therapeutics | 424B5: Prospectus
Jan 8, 2021 17:02 ET
Avalo Therapeutics | 424B5: Prospectus
Jan 7, 2021 17:07 ET
Avalo Therapeutics | 424B5: Prospectus
Jun 9, 2020 17:22 ET
Avalo Therapeutics | 424B5: Prospectus
Jun 8, 2020 16:03 ET
Avalo Therapeutics | EFFECT: Others
May 19, 2020 00:15 ET
Avalo Therapeutics | 424B3: Prospectus
May 18, 2020 16:41 ET
Avalo Therapeutics | 424B5: Prospectus
Feb 4, 2020 16:46 ET
Avalo Therapeutics | 424B3: Prospectus
Jan 6, 2020 17:47 ET
Avalo Therapeutics | EFFECT: Others
Jan 2, 2020 00:15 ET
Avalo Therapeutics | S-4/A: Registration of securities issued in business combination transactions (Amendment)
Dec 30, 2019 16:07 ET
Avalo Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Dec 23, 2019 07:31 ET
No Data
No Data